Additionally, FOXA1 enhances antitumor immunity and reduces immune evasion in NPC by interacting with STAT1 to inhibit IRF1 transcription, thereby suppressing IFN-γ-induced PD-L1 expression [43]. The gene discussed is IRF1; the disease is nasopharyngeal carcinoma.